A pair of widely used medications—long approved for abortion but also effective in treating common gynecological conditions like uterine fibroids and endometriosis—are now at the center of legal and medical debates. As anti-abortion advocates push for stricter regulations, a new investigation explores how these same drugs offer critical relief for women facing painful and debilitating reproductive health disorders. The report examines the broader implications of restricting access to treatments that have helped millions beyond their original purpose. For those following the evolving landscape of reproductive healthcare, this deeper look into the drugs’ dual role is essential viewing.
For more than 25 years, mifepristone has been approved for abortion in the U.S. But mifepristone and a similar drug have also been proven to treat conditions like uterine fibroids and endometriosis. As anti-abortion groups lobby to further restrict these drugs, Special correspondent Sarah Varney and producer Rachel Wellford take a look at these treatments. It's for our series, Beyond Abortion.
